Therapeutic substituted cyclopentanes

Details for Australian Patent Application No. 2009246573 (hide)

Owner Allergan, Inc.

Inventors Gac, Todd S.; Ngo, Vinh X.; Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2009246573

PCT Pub. Number WO2009/140205

Priority 61/053,354 15.05.08 US

Filing date 11 May 2009

Wipo publication date 19 November 2009

International Classifications

C07C 59/72 (2006.01) Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07C 409/02 (2006.01) Peroxy compounds

C07D 333/40 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/140205 Priority application(s): WO2009/140205

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246599-Method of forming a reconstituted wood block

2009246572-Selective subtype alpha 2 adrenergic agents and methods for use thereof